Decreased Expression of microRNA-451 is Associated with Imatinib Mesylate Resistance in Chronic Myeloid Leukemia Patients

被引：0
|
作者：
Khalifa, Khaled [1 ]
Abbas, Omaima [2 ]
Abdlfattah, Raafat [3 ]
Alhassanin, Suzan [4 ]
Shehata, Amira [1 ]
Esawy, Sally [2 ]
机构：
[1] Menoufia Univ, Dept Clin Pathol, Fac Med, Shibin Al Kawm, Egypt
[2] Menoufia Univ, Natl Liver Inst, Dept Clin Pathol, Shibin Al Kawm, Egypt
[3] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt
[4] Menoufia Univ, Dept Clin Oncol, Fac Med, Shibin Al Kawm, Egypt
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
imatinib mesylate; microRNA-451; real-time polymerase chain reaction; CML; chronic myelogenous leukemia;
D O I：
10.1016/j.clml.2019.07.240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-165
引用
收藏
页码：S293 / S293
页数：1
相关论文
共 50 条
  • [31] MULTIPLE PATHS TO DRUG RESISTANCE PHENOTYPE IN CHRONIC MYELOID LEUKEMIA PATIENTS UNDERGOING IMATINIB MESYLATE TREATMENT
    Ankathil, Ravindran
    Zahry, Mohd Khairi
    Hassan, Rosline
    Dzarr, Abu
    Peng, Hoh Boon
    Baba, Abdul Aziz
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3198 - 3198
  • [32] Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia
    Barnes, DJ
    Palaiologou, D
    Panousopoulou, E
    Schultheis, B
    Yong, ASM
    Wong, A
    Pattacini, L
    Goldman, JM
    Melo, JV
    CANCER RESEARCH, 2005, 65 (19) : 8912 - 8919
  • [33] Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?
    Akay, Olga Meltem
    Mutlu, Fezan
    Gulbas, Zafer
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 127 - 130
  • [34] Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation
    Merante, Serena
    Orlandi, Ester
    Bernasconi, Paolo
    Calatroni, Silvia
    Boni, Marina
    Lazzarino, Mario
    HAEMATOLOGICA, 2005, 90 (07) : 979 - 981
  • [35] Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia
    Flamant, Stephane
    Ritchie, William
    Guilhot, Joelle
    Holst, Jeff
    Bonnet, Marie-Laure
    Chomel, Jean-Claude
    Guilhot, Francois
    Turhan, Ali G.
    Rasko, John E. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08): : 1325 - 1333
  • [36] How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
    Hasford, J
    Pfirrmann, M
    Hochhaus, A
    LEUKEMIA, 2005, 19 (04) : 497 - 499
  • [37] Development of a test to predict resistance to imatinib mesylate in the treatment of chronic myeloid leukemia.
    Schultheis, B
    Fidanis, E
    Mahon, FX
    Apperley, JF
    Goldman, JM
    Melo, JV
    BLOOD, 2003, 102 (11) : 71A - 72A
  • [38] Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)
    Walz, C
    Sattler, M
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 57 (02) : 145 - 164
  • [39] How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
    J Hasford
    M Pfirrmann
    A Hochhaus
    Leukemia, 2005, 19 : 497 - 499
  • [40] Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate
    Jabbour, E
    Kantarjian, H
    O'Brien, S
    Rios, MB
    Abruzzo, L
    Verstovsek, S
    Garcia-Manero, G
    Cortes, J
    BLOOD, 2006, 107 (02) : 480 - 482
12345